dralindar.bsky.social
@dralindar.bsky.social
Aspiring Pharmacist interested in critical care, cardiology, and infectious diseases.
Reposted
Looking for the latest guidance on intra-abdominal infxns? SIDP has you covered! 😍

Check out this infographic on new #SIS IAI Guidelines developed by Dr. Clara Ni! 💊 This medical education provided by an educational grant from Innoviva Specialty Therapeutics. Download: https://buff.ly/4jrr8Vy
January 22, 2025 at 10:54 PM
Reposted
Doxy and tige and erava – oh my!  How do you differentiate their spectra of activity?  🤨 With this handy infographic!  Developed by SIDP members and sponsored by Innoviva Specialty Therapeutics
January 23, 2025 at 1:00 PM
Reposted
Happy New Year, @absteward.bsky.social style! 🎉
Kicking off 2025 with this gem:
🆕💫 How accurate is ceftriaxone at predicting susceptibility of enterobacterales isolates to oral higher-generation cephalosporins? #idsky #EMIMCC
journals.asm.org/doi/10.1128/...
How accurate is ceftriaxone at predicting susceptibility of enterobacterales isolates to oral higher-generation cephalosporins? | Antimicrobial Agents and Chemotherapy
There is a growing body of evidence supporting early transition to oral antibiotic therapy to complete treatment courses for gram-negative bloodstream infections (GN-BSI) (1–3). Most available data fo...
journals.asm.org
December 31, 2024 at 7:34 PM